Deontics, a medtech spin-out of Oxford University, has secured a £700,000 ($1.15m) investment. Investors include John McMonigall, former head of technology investments at venture capital firm Apax Partners.
Based on ten years of research by John Fox at Oxford’s Engineering Department, the company commercialises software that creates personalised treatment guides for patients by analysing all relevant scientific and clinical information.
The technology is already in use at the Royal Free Hospital in London, where it supported the treatment of several…
